Evidence map›Paper›PMID 39125261›Full record

Trial reportNutrients2024

Sourdough Bread with Different Fermentation Times: A Randomized Clinical Trial in Subjects with Metabolic Syndrome.

Karla Alejandra Pérez-Vega, Albert Sanllorente, María-Dolores Zomeño, Ana Quindós, Júlia Muñoz-Martínez, Mireia Malcampo, Ana Aldea-Perona, Álvaro Hernáez, Aleix Lluansí, Marc Llirós and 13 more

Abstract readRandomized Controlled Trial
In one paragraph

Trial report in Nutrients, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

23 authors.

Karla Alejandra Pérez-VegaHospital del Mar Research Institute, 08003 Barcelona, Spain.ORCID 0000-0002-7524-2034
Albert SanllorenteHospital del Mar Research Institute, 08003 Barcelona, Spain.
María-Dolores ZomeñoHospital del Mar Research Institute, 08003 Barcelona, Spain.ORCID 0000-0003-1280-7680
Ana QuindósHospital del Mar Research Institute, 08003 Barcelona, Spain.
Júlia Muñoz-MartínezHospital del Mar Research Institute, 08003 Barcelona, Spain.ORCID 0000-0002-1817-8937
Mireia MalcampoHospital del Mar Research Institute, 08003 Barcelona, Spain.
Ana Aldea-PeronaHospital del Mar Research Institute, 08003 Barcelona, Spain.
Álvaro HernáezHospital del Mar Research Institute, 08003 Barcelona, Spain.
Aleix LluansíDigestive Diseases and Microbiota Group, Institut d'Investigació Biomèdica de Girona, 17190 Salt, Spain.ORCID 0000-0002-2328-6780
Marc LlirósDigestive Diseases and Microbiota Group, Institut d'Investigació Biomèdica de Girona, 17190 Salt, Spain.ORCID 0000-0001-8456-4230
Isidre EliasElias-Boulanger S.L., 08340 Vilassar de Mar, Spain.
Núria Elias-MasiquesElias-Boulanger S.L., 08340 Vilassar de Mar, Spain.
Xavier AldeguerDigestive Diseases and Microbiota Group, Institut d'Investigació Biomèdica de Girona, 17190 Salt, Spain.
Daniel MuñozHospital del Mar Research Institute, 08003 Barcelona, Spain.
Sònia GaixasHospital del Mar Research Institute, 08003 Barcelona, Spain.
Gemma BlanchartHospital del Mar Research Institute, 08003 Barcelona, Spain.
Helmut SchröderHospital del Mar Research Institute, 08003 Barcelona, Spain.
Javier Hernando-RedondoHospital del Mar Research Institute, 08003 Barcelona, Spain.ORCID 0000-0002-6777-1649
Nerea CarrónMicroomics Systems S.L., 08041 Barcelona, Spain.
Pedro González-TorresMicroomics Systems S.L., 08041 Barcelona, Spain.
Valentini KonstantinidouMedoliali S.L. (DNANUTRICOACH®), 08006 Barcelona, Spain.
Montserrat FitóHospital del Mar Research Institute, 08003 Barcelona, Spain.
Olga CastañerHospital del Mar Research Institute, 08003 Barcelona, Spain.

Funding

Agència de Gestió d'Ajuts Universitaris i de Recerca 2021 SGR 00144Instituto de Salud Carlos III CP21/00097Instituto de Salud Carlos III IFI16/00011Instituto de Salud Carlos III IFI20/00002Instituto de Salud Carlos III PI17/00214Instituto de Salud Carlos III PI18/00020Instituto de Salud Carlos III PI20/00012Ministry of Economy, Industry and Competitiveness (MINECO) RETOS program RTC-2017-6467-2
6 · The paper itself

Abstract

The Mediterranean diet, featuring sourdough bread, shows promise in managing metabolic syndrome. This study explored the effects of two sourdough breads, with differing fermentation times but similar nutritional profiles, on inflammation, satiety, and gut microbiota composition in adults with metabolic syndrome. In a double-blind clinical trial, participants were randomized to consume either Elias Boulanger

Indexed as

BreadDiet, MediterraneanFermentationGastrointestinal MicrobiomeMetabolic SyndromeAgedBiomarkersDouble-Blind MethodFemaleHumansInflammationIntercellular Adhesion Molecule-1MaleMiddle AgedPlasminogen Activator Inhibitor 1Time FactorsBiomarkersIntercellular Adhesion Molecule-1Plasminogen Activator Inhibitor 1blood pressuremetabolic syndromePAI-1sICAMsourdough bread

Identifiers

PMID39125261
PMCPMC11314010

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.